Pediatric adrenocortical tumors (pACTs) are rare endocrine neoplasms with variable prognosis, commonly associated with germline pathogenic variants (PVs) in the tumor suppressor gene TP53. Here, we
Published: April 17, 2025 Explor Endocr Metab Dis. 2025;2:101429
Diabetes mellitus is a major risk factor for both cardiovascular and chronic kidney disease (CKD) while CKD is also associated with cardiovascular morbidity. In fact, cardiovascular disease is the l
Published: April 15, 2025 Explor Endocr Metab Dis. 2025;2:101428
Obesity is a multifactorial disease linked to many comorbidities and has an impact on brain health. It is also known that obesity disrupts the endocannabinoid (eCB) system in the central nervous sys
Published: April 07, 2025 Explor Endocr Metab Dis. 2025;2:101427
The glucocorticoid receptor alpha (GRα), a vital component of the ancient glucocorticoid (GC) signaling system, is essential for vertebrate survival. It regulates fertility, fetal development, orga
Published: March 28, 2025 Explor Endocr Metab Dis. 2025;2:101426
Metabolic dysfunction-associated steatotic liver disease (MASLD) is rapidly emerging as a global health crisis, affecting over 30% of the population and demanding urgent attention. This redefined co
Published: March 25, 2025 Explor Endocr Metab Dis. 2025;2:101425
The accumulation of adipose tissue is associated with metabolic disorders, including insulin resistance, type 2 diabetes (T2D), dyslipidemia, metabolic syndrome, and cardiovascular diseases (CVD). M
Published: March 13, 2025 Explor Endocr Metab Dis. 2025;2:101424
The escalating prevalence of diabetes poses a significant health concern. Uncontrolled diabetes leads to a multitude of complications. A comprehensive management plan and continual adaptation of gui
Published: July 23, 2024 Explor Endocr Metab Dis. 2024;1:158–166
Artificial intelligence (AI) has gained attention for various reasons in recent years, surrounded by speculation, concerns, and expectations. Despite being developed since 1960, its widespread appli
Published: April 01, 2024 Explor Endocr Metab Dis. 2024;1:16–26
Aim:
Current diabetes guidelines recommend people with gestational diabetes mellitus (PwGDM) use primarily blood glucose meters (BGM) for diabetes management. We evaluated glycemic trends and gui
Published: July 24, 2024 Explor Endocr Metab Dis. 2024;1:167–176
A 74-year-old male patient with beta thalassemia minor presented in 2022 for a follow-up of osteoporosis diagnosed prior to 2004. At the time of presentation, his medical history included: radiation
Published: October 31, 2024 Explor Endocr Metab Dis. 2024;1:213–217
Stress hormones, namely glucocorticoids, have diverse actions throughout the body in regulating development, tissue metabolism, inflammation, circadian rhythms, and skeletal homeostasis. While endog
Published: August 16, 2024 Explor Endocr Metab Dis. 2024;1:191–212
Adult-onset testosterone deficiency (TD) in men is diagnosed by the finding of low serum testosterone levels and recognised, associated symptoms. The condition has high prevalence in men over 50 yea
Published: June 28, 2024 Explor Endocr Metab Dis. 2024;1:83–100
Artificial intelligence (AI) has gained attention for various reasons in recent years, surrounded by speculation, concerns, and expectations. Despite being developed since 1960, its widespread appli
Published: April 01, 2024 Explor Endocr Metab Dis. 2024;1:16–26
Stress hormones, namely glucocorticoids, have diverse actions throughout the body in regulating development, tissue metabolism, inflammation, circadian rhythms, and skeletal homeostasis. While endog
Published: August 16, 2024 Explor Endocr Metab Dis. 2024;1:191–212
A 74-year-old male patient with beta thalassemia minor presented in 2022 for a follow-up of osteoporosis diagnosed prior to 2004. At the time of presentation, his medical history included: radiation
Published: October 31, 2024 Explor Endocr Metab Dis. 2024;1:213–217
Pheochromocytomas (PCCs) and paragangliomas (PGLs; together PPGLs) are uncommon neuroendocrine tumors arising from adrenal medullary chromaffin cells and sympathetic/parasympathetic paraganglia. Tho
Published: November 15, 2024 Explor Endocr Metab Dis. 2024;1:218–233
The escalating prevalence of diabetes poses a significant health concern. Uncontrolled diabetes leads to a multitude of complications. A comprehensive management plan and continual adaptation of gui
Published: July 23, 2024 Explor Endocr Metab Dis. 2024;1:158–166
Aim:
Current diabetes guidelines recommend people with gestational diabetes mellitus (PwGDM) use primarily blood glucose meters (BGM) for diabetes management. We evaluated glycemic trends and gui
Published: July 24, 2024 Explor Endocr Metab Dis. 2024;1:167–176
Aim:
Metabolic syndrome (MetS) is associated with chronic conditions, including type 2 diabetes mellitus (T2DM) and cardiovascular disorders. New markers are needed for the early detection and su
Published: January 10, 2025 Explor Endocr Metab Dis. 2025;2:101421
Artificial intelligence (AI) has gained attention for various reasons in recent years, surrounded by speculation, concerns, and expectations. Despite being developed since 1960, its widespread appli
Published: April 01, 2024 Explor Endocr Metab Dis. 2024;1:16–26
Aim:
Regenerative and curative strategies would be desirable for neurodegenerative and adrenal diseases, and multipotent adrenal stem cells are considered as promising biological tools for this p
Published: April 01, 2024 Explor Endocr Metab Dis. 2024;1:27–38
The escalating prevalence of diabetes poses a significant health concern. Uncontrolled diabetes leads to a multitude of complications. A comprehensive management plan and continual adaptation of gui
Published: July 23, 2024 Explor Endocr Metab Dis. 2024;1:158–166
Aim:
To evaluate changes in quality of life via the ageing male symptom scale (AMSS) and somatic, psychological, and sexual sub-scales following testosterone undecanoate (TU) or placebo (P) treat
Published: August 13, 2024 Explor Endocr Metab Dis. 2024;1:177–190
For the past 100 years, insulin supplementation has been the mainstay of treatment for type 1 diabetes (T1D), which is characterized by progressive autoimmune-mediated loss of insulin-producing β c
Published: April 01, 2024 Explor Endocr Metab Dis. 2024;1:4–11